Atlas Trials

Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody

Clinical trial NCT00431275 · COMPLETED

Trial details

NCT number
NCT00431275
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Melanoma
Start date
2006-06-01
Primary completion
2008-02-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.